Clinical Trial: Caplyta Versus Placebo for Adults With Social Anxiety Disorder

U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07799493) titled 'Caplyta Versus Placebo for Adults With Social Anxiety Disorder' on Aug. 28.

Brief Summary: The goal of this clinical trial is to learn if Caplyta works to treat Social Anxiety Disorder in adults. The main question it aims to answer is:

Does Caplyta lower the frequency/severity of social anxiety symptoms in adults?

Researchers will compare Caplyta to a placebo (a look-alike substance that contains no drug) to see if Caplyta works to treat Social Anxiety Disorder.

Participants will:

Take Caplyta or a placebo every day for 8 weeks Visit the clinic once every week for checkups and tests

Study Start Date: Aug. 18

Study Type: INTERV...